(Q39579621)

13 September 2017

title

Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes (English)

1 reference

13 September 2017

1 reference

Emmenegger U

1

1 reference

13 September 2017

Frey U

2

1 reference

13 September 2017

Reimers A

3

1 reference

13 September 2017

Fux C

4

1 reference

13 September 2017

Semela D

5

1 reference

13 September 2017

Cottagnoud P

6

1 reference

13 September 2017

Spaeth PJ

7

1 reference

13 September 2017

Neftel KA

8

1 reference

13 September 2017

publication date

1 September 2001

1 reference

American Journal of Hematology

13 September 2017

published in

1 reference

13 September 2017

volume

68

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

4-10

1 reference

Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment

13 September 2017

cites work

1 reference

Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

Hyperferritinemia in malignant histiocytosis, virus-associated hemophagocytic syndrome and familial erythrophagocytic lymphohistiocytosis. A survey of pediatric cases

21 January 2018

1 reference

Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis

21 January 2018

1 reference

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

21 January 2018

1 reference

Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France

21 January 2018

1 reference

Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin

21 January 2018

1 reference

Mechanism of action of intravenous immunoglobulin in immune-mediated cytopenias

21 January 2018

1 reference

Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy

21 January 2018

1 reference

Autoantibodies to cytokines

21 January 2018

1 reference

Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model

21 January 2018

1 reference

High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments

21 January 2018

1 reference

Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain

21 January 2018

1 reference

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases.

21 January 2018

1 reference

Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance

21 January 2018

1 reference

Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis

21 January 2018

1 reference

[Still's disease in adults: treatment with intravenous immunoglobulins]

21 January 2018

1 reference

Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy

21 January 2018

1 reference

Elevation of soluble Fas and soluble Fas ligand in reactive macrophage activation syndromes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.1141

1 reference

13 September 2017

1 reference